Voltage-gated sodium channel and adrenergic receptor combination (VGSC/AR)

Voltage-gated sodium channels (VGSCs) are transmembrane proteins essential for the generation and propagation of action potentials in neurons and muscle cells (UniProt, 2024). Adrenergic receptors (ARs) are a class of G protein-coupled receptors that mediate the physiological responses to catecholamines like epinephrine and norepinephrine (NCBI, 2023). The combination of VGSCs and ARs as a therapeutic focus is primarily seen in the field of local anesthesia, where sodium channel blockers are paired with adrenergic agonists. VGSC inhibition prevents the transmission of pain signals by blocking the influx of sodium ions into nerve fibers (StatPearls, 2023). Simultaneously, the activation of alpha-adrenergic receptors causes localized vasoconstriction, which limits the systemic distribution of the anesthetic agent (PubMed, 2022). This synergistic approach increases the depth and duration of the anesthetic block while reducing the potential for systemic toxicity (NIH, 2023). Clinically, this combination is vital for surgical and dental procedures requiring prolonged localized pain control. However, the inclusion of adrenergic components necessitates caution in patients with cardiovascular disease due to the risk of induced arrhythmias or hypertension.

Other names

Sodium channel and adrenoceptor combinationLocal anesthetic and vasoconstrictor combinationVGSC and AR co-targeting

Inhibition of voltage-gated sodium channels to block nerve conduction combined with activation of adrenergic receptors to induce local vasoconstriction, thereby prolonging the anesthetic effect and reducing systemic absorption (StatPearls, 2023).